Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic PS128 in Children With Autism Spectrum Disorder
NCT04942522Phase 1Unknown
- Start
- Jun 2021
- Primary completion
- Jun 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lactobacillus plantarum PS128 in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoints: Autism Diagnostic Observation Schedule at 20 weeks, Social Responsiveness Scale at 20 weeks and 7 more. Status: unknown.
02
Drugs
lactobacillus plantarum PS128
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04942522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04942522.